Management of a Major Carbapenem-Resistant Acinetobacter baumannii Outbreak in a French Intensive Care Unit While Maintaining Its Capacity Unaltered

We describe bundle measures implemented to overcome a protracted carbapenem-resistant Acinetobacter baumannii (CRAB) outbreak in an 18-bed trauma Intensive Care Unit (ICU) at Strasbourg University Hospital, a tertiary referral center in France. Outbreak cases were defined by a positive CRAB sample with OXA-23 profile during or after ICU say. To sustain the capacity of the busy trauma ICU, infection control bundles were purposely selected to control the outbreak without closing the ICU. During the outbreak, from May 2015 to January 2019, 141 patients were contaminated by CRAB, including 91 colonized and 50 infected patients. The conventional infection and prevention control (IPC) measures implemented included weekly active surveillance of patients’ samples, enhancement of environmental cleaning, interventions to improve hand hygiene compliance and antibiotic stewardship with audits. Supplemental measures were needed, including environmental samplings, health care workers’ (HCWs) hand sampling, chlorhexidine body-washing, relocation of the service to implement Airborne Disinfection System (ADS), replication of crisis cells, replacement of big environmental elements and improvement of HCW organization at the patient’s bedside. The final measure was the cohorting of both CRAB patients and HCW caring for them. Only the simultaneous implementation of aggressive and complementary measures made it possible to overcome this long-lasting CRAB epidemic. Facing many CRAB cases during a rapidly spreading outbreak, combining simultaneous aggressive and complementary measures (including strict patients and HCW cohorting), was the only way to curb the epidemic while maintaining ICU capacity.

[1]  R. Vonberg,et al.  Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review , 2018, American journal of infection control.

[2]  A. Apisarnthanarak,et al.  A Systematic Review of the Burden of Multidrug-Resistant Healthcare-Associated Infections Among Intensive Care Unit Patients in Southeast Asia: The Rise of Multidrug-Resistant Acinetobacter baumannii , 2018, Infection Control & Hospital Epidemiology.

[3]  S. Lévesque,et al.  Management of a hospital outbreak of extensively drug-resistant Acinetobacter baumannii using a multimodal intervention including daily chlorhexidine baths. , 2016, The Journal of hospital infection.

[4]  N. Namias,et al.  Carbapenem-Resistant Acinetobacter baumannii: Concomitant Contamination of Air and Environmental Surfaces , 2016, Infection Control & Hospital Epidemiology.

[5]  A. Gikas,et al.  multidrug-resistant Gram-negative bacteria in EU countries , 2015 .

[6]  J. Timsit,et al.  Task force on management and prevention of Acinetobacter baumannii infections in the ICU , 2015, Intensive Care Medicine.

[7]  M. Hoshen,et al.  Risk factors for and impact of carbapenem-resistant Acinetobacter baumannii colonization and infection: matched case–control study , 2015, European Journal of Clinical Microbiology & Infectious Diseases.

[8]  Y. Chuang,et al.  The Impact of Inadequate Terminal Disinfection on an Outbreak of Imipenem-Resistant Acinetobacter baumannii in an Intensive Care Unit , 2014, PloS one.

[9]  D. Morgan,et al.  Preventing the Transmission of Multidrug-Resistant Organisms: Modeling the Relative Importance of Hand Hygiene and Environmental Cleaning Interventions , 2014, Infection Control & Hospital Epidemiology.

[10]  E. Pérez-Rodríguez,et al.  Influence of whole-body washing of critically ill patients with chlorhexidine on Acinetobacter baumannii isolates. , 2014, American journal of infection control.

[11]  K. Kaye,et al.  Effectiveness and cost of implementing an active surveillance screening policy for Acinetobacter baumannii: a Monte Carlo simulation model. , 2014, American journal of infection control.

[12]  Jane D. Single... Management of Multidrug- resistant organisms in Healthcare settings , 2013 .

[13]  D. Warren,et al.  Screening for carbapenem-resistant Acinetobacter baumannii colonization sites: an implication for combination of horizontal and vertical approaches. , 2013, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[14]  Donoghue,et al.  Acinetobacter baumannii , 2012, Virulence.

[15]  M. Jackson,et al.  Management of multidrug-resistant organisms in health care settings, 2006. , 2007, American journal of infection control.

[16]  Y. Carmeli,et al.  Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes , 2007, European Journal of Clinical Microbiology & Infectious Diseases.

[17]  Y. Carmeli,et al.  Surveillance Cultures and Duration of Carriage of Multidrug-Resistant Acinetobacter baumannii , 2007, Journal of Clinical Microbiology.

[18]  S. Alfandari Origine et attente des référents antibiotiques dans les établissements de santé en France. Résultats d'une enquête de la SPILF , 2006 .

[19]  Jonathan R Edwards,et al.  Overview of nosocomial infections caused by gram-negative bacilli. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[20]  J. Lucet,et al.  An Outbreak of Imipenem-Resistant Acinetobacter baumannii in Critically Ill Surgical Patients , 2001, Infection Control & Hospital Epidemiology.

[21]  G. Wang,et al.  A Nosocomial Outbreak of Multiresistant Acinetobacter baumannii Originating From an Intensive Care Unit , 2001, Infection Control & Hospital Epidemiology.

[22]  J. Ariza,et al.  Environmental Sampling of Acinetobacter baumannii: Moistened Swabs Versus Moistened Sterile Gauze Pads , 1999, Infection Control & Hospital Epidemiology.

[23]  B. Cookson,et al.  ESCMID guidelines for the management of the infection control measures to reduce transmission of multidrug-resistant Gram-negative bacteria in hospitalized patients. , 2014, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.